Table of Content

1 Study Coverage
1.1 Lung Disease Therapeutic Drug Product Introduction
1.2 Global Lung Disease Therapeutic Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Lung Disease Therapeutic Drug Sales in US$ Million for the Year 2018-2034
1.2.2 Global Lung Disease Therapeutic Drug Sales in Volume for the Year 2018-2034
1.3 India Lung Disease Therapeutic Drug Outlook 2018 VS 2024 VS 2034
1.3.1 India Lung Disease Therapeutic Drug Sales in US$ Million for the Year 2018-2034
1.3.2 India Lung Disease Therapeutic Drug Sales in Volume for the Year 2018-2034
1.4 Lung Disease Therapeutic Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Lung Disease Therapeutic Drug in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Lung Disease Therapeutic Drug Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Lung Disease Therapeutic Drug Market Dynamics
1.5.1 Lung Disease Therapeutic Drug Industry Trends
1.5.2 Lung Disease Therapeutic Drug Market Drivers
1.5.3 Lung Disease Therapeutic Drug Market Challenges
1.5.4 Lung Disease Therapeutic Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Lung Disease Therapeutic Drug by Type
2.1 Lung Disease Therapeutic Drug Market Segment by Type
2.1.1 Corticosteroids
2.1.2 Bronchodilator Medications
2.1.3 Mucolytics
2.1.4 Antimicrobial Medications
2.1.5 Others
2.2 Global Lung Disease Therapeutic Drug Market Size by Type
2.2.1 Global Lung Disease Therapeutic Drug Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Lung Disease Therapeutic Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Lung Disease Therapeutic Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Lung Disease Therapeutic Drug Market Size by Type
2.3.1 India Lung Disease Therapeutic Drug Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Lung Disease Therapeutic Drug Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Lung Disease Therapeutic Drug Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Lung Disease Therapeutic Drug by Application
3.1 Lung Disease Therapeutic Drug Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Lung Disease Therapeutic Drug Market Size by Application
3.2.1 Global Lung Disease Therapeutic Drug Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Lung Disease Therapeutic Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Lung Disease Therapeutic Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Lung Disease Therapeutic Drug Market Size by Application
3.3.1 India Lung Disease Therapeutic Drug Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Lung Disease Therapeutic Drug Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Lung Disease Therapeutic Drug Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Lung Disease Therapeutic Drug Competitor Landscape by Company
4.1 Global Lung Disease Therapeutic Drug Market Size by Company
4.1.1 Global Key Manufacturers of Lung Disease Therapeutic Drug, Ranked by Revenue (2024)
4.1.2 Global Lung Disease Therapeutic Drug Revenue by Manufacturer (2018-2023)
4.1.3 Global Lung Disease Therapeutic Drug Sales by Manufacturer (2018-2023)
4.1.4 Global Lung Disease Therapeutic Drug Price by Manufacturer (2018-2023)
4.2 Global Lung Disease Therapeutic Drug Concentration Ratio (CR)
4.2.1 Lung Disease Therapeutic Drug Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Lung Disease Therapeutic Drug in 2024
4.2.3 Global Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Lung Disease Therapeutic Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Lung Disease Therapeutic Drug, Product Offered and Application
4.5 Global Key Manufacturers of Lung Disease Therapeutic Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Lung Disease Therapeutic Drug Market Size by Company
4.7.1 Key Players of Lung Disease Therapeutic Drug in India, Ranked by Revenue (2024)
4.7.2 India Lung Disease Therapeutic Drug Revenue by Players (2018-2023)
4.7.3 India Lung Disease Therapeutic Drug Sales by Players (2018-2023)
5 Global Lung Disease Therapeutic Drug Market Size by Region
5.1 Global Lung Disease Therapeutic Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Lung Disease Therapeutic Drug Market Size in Volume by Region (2018-2034)
5.2.1 Global Lung Disease Therapeutic Drug Sales in Volume by Region: 2018-2023
5.2.2 Global Lung Disease Therapeutic Drug Sales in Volume Forecast by Region (2024-2034)
5.3 Global Lung Disease Therapeutic Drug Market Size in Value by Region (2018-2034)
5.3.1 Global Lung Disease Therapeutic Drug Sales in Value by Region: 2018-2023
5.3.2 Global Lung Disease Therapeutic Drug Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Lung Disease Therapeutic Drug Market Size YoY Growth 2018-2034
6.2 Americas Lung Disease Therapeutic Drug Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Lung Disease Therapeutic Drug Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Lung Disease Therapeutic Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Lung Disease Therapeutic Drug Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Lung Disease Therapeutic Drug Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Lung Disease Therapeutic Drug Market Size YoY Growth 2018-2034
7.2 EMEA Lung Disease Therapeutic Drug Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Lung Disease Therapeutic Drug Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Lung Disease Therapeutic Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Lung Disease Therapeutic Drug Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Lung Disease Therapeutic Drug Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Lung Disease Therapeutic Drug Market Size YoY Growth 2018-2034
8.2 China Lung Disease Therapeutic Drug Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Lung Disease Therapeutic Drug Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Lung Disease Therapeutic Drug Market Size YoY Growth 2018-2034
9.2 APAC Lung Disease Therapeutic Drug Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Lung Disease Therapeutic Drug Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Lung Disease Therapeutic Drug Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Lung Disease Therapeutic Drug Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Lung Disease Therapeutic Drug Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Description and Business Overview
10.1.3 GSK Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Lung Disease Therapeutic Drug Products Offered
10.1.5 GSK Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Description and Business Overview
10.2.3 AstraZeneca Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Lung Disease Therapeutic Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Description and Business Overview
10.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Lung Disease Therapeutic Drug Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Description and Business Overview
10.4.3 Novartis Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Lung Disease Therapeutic Drug Products Offered
10.4.5 Novartis Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Description and Business Overview
10.5.3 Mylan Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Lung Disease Therapeutic Drug Products Offered
10.5.5 Mylan Recent Development
10.6 Vertex Pharmaceuticals
10.6.1 Vertex Pharmaceuticals Company Information
10.6.2 Vertex Pharmaceuticals Description and Business Overview
10.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Products Offered
10.6.5 Vertex Pharmaceuticals Recent Development
10.7 F. Hoffman La Roche
10.7.1 F. Hoffman La Roche Company Information
10.7.2 F. Hoffman La Roche Description and Business Overview
10.7.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 F. Hoffman La Roche Lung Disease Therapeutic Drug Products Offered
10.7.5 F. Hoffman La Roche Recent Development
10.8 Teva Pharmaceuticals
10.8.1 Teva Pharmaceuticals Company Information
10.8.2 Teva Pharmaceuticals Description and Business Overview
10.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Drug Products Offered
10.8.5 Teva Pharmaceuticals Recent Development
10.9 Cipla
10.9.1 Cipla Company Information
10.9.2 Cipla Description and Business Overview
10.9.3 Cipla Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Cipla Lung Disease Therapeutic Drug Products Offered
10.9.5 Cipla Recent Development
10.10 Fibrogen
10.10.1 Fibrogen Company Information
10.10.2 Fibrogen Description and Business Overview
10.10.3 Fibrogen Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Fibrogen Lung Disease Therapeutic Drug Products Offered
10.10.5 Fibrogen Recent Development
10.11 Liminal Biosciences
10.11.1 Liminal Biosciences Company Information
10.11.2 Liminal Biosciences Description and Business Overview
10.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Liminal Biosciences Lung Disease Therapeutic Drug Products Offered
10.11.5 Liminal Biosciences Recent Development
10.12 PharmAkea Therapeutics
10.12.1 PharmAkea Therapeutics Company Information
10.12.2 PharmAkea Therapeutics Description and Business Overview
10.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Drug Products Offered
10.12.5 PharmAkea Therapeutics Recent Development
10.13 IQVIA
10.13.1 IQVIA Company Information
10.13.2 IQVIA Description and Business Overview
10.13.3 IQVIA Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 IQVIA Lung Disease Therapeutic Drug Products Offered
10.13.5 IQVIA Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Lung Disease Therapeutic Drug Industry Chain Analysis
11.2 Lung Disease Therapeutic Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Lung Disease Therapeutic Drug Production Mode & Process
11.4 Lung Disease Therapeutic Drug Sales and Marketing
11.4.1 Lung Disease Therapeutic Drug Sales Channels
11.4.2 Lung Disease Therapeutic Drug Distributors
11.5 Lung Disease Therapeutic Drug Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Lung Disease Therapeutic Drug CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Lung Disease Therapeutic Drug Market Trends
Table 3. Lung Disease Therapeutic Drug Market Drivers
Table 4. Lung Disease Therapeutic Drug Market Challenges
Table 5. Lung Disease Therapeutic Drug Market Restraints
Table 6. Global Lung Disease Therapeutic Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Lung Disease Therapeutic Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Lung Disease Therapeutic Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Lung Disease Therapeutic Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Lung Disease Therapeutic Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Lung Disease Therapeutic Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Lung Disease Therapeutic Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global Lung Disease Therapeutic Drug Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Lung Disease Therapeutic Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global Lung Disease Therapeutic Drug Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Lung Disease Therapeutic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Lung Disease Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic Drug as of 2024)
Table 18. Global Key Manufacturers of Lung Disease Therapeutic Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Lung Disease Therapeutic Drug, Product Offered and Application
Table 20. Global Key Manufacturers of Lung Disease Therapeutic Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Lung Disease Therapeutic Drug in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Lung Disease Therapeutic Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Lung Disease Therapeutic Drug Revenue Share by Players, (2018-2023)
Table 25. India Lung Disease Therapeutic Drug Sales by Players, (K Units), (2018-2023)
Table 26. India Lung Disease Therapeutic Drug Sales Share by Players, (2018-2023)
Table 27. Global Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Lung Disease Therapeutic Drug Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Lung Disease Therapeutic Drug Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Lung Disease Therapeutic Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Lung Disease Therapeutic Drug Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Lung Disease Therapeutic Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Lung Disease Therapeutic Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Lung Disease Therapeutic Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Lung Disease Therapeutic Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Lung Disease Therapeutic Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Lung Disease Therapeutic Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Lung Disease Therapeutic Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Lung Disease Therapeutic Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Lung Disease Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Lung Disease Therapeutic Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Lung Disease Therapeutic Drug Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Lung Disease Therapeutic Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Lung Disease Therapeutic Drug Sales in Volume by Country (2024-2034) & (K Units)
Table 47. GSK Company Information
Table 48. GSK Description and Business Overview
Table 49. GSK Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. GSK Lung Disease Therapeutic Drug Product
Table 51. GSK Recent Development
Table 52. AstraZeneca Company Information
Table 53. AstraZeneca Description and Business Overview
Table 54. AstraZeneca Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. AstraZeneca Lung Disease Therapeutic Drug Product
Table 56. AstraZeneca Recent Development
Table 57. Boehringer Ingelheim Company Information
Table 58. Boehringer Ingelheim Description and Business Overview
Table 59. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Boehringer Ingelheim Lung Disease Therapeutic Drug Product
Table 61. Boehringer Ingelheim Recent Development
Table 62. Novartis Company Information
Table 63. Novartis Description and Business Overview
Table 64. Novartis Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Novartis Lung Disease Therapeutic Drug Product
Table 66. Novartis Recent Development
Table 67. Mylan Company Information
Table 68. Mylan Description and Business Overview
Table 69. Mylan Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Mylan Lung Disease Therapeutic Drug Product
Table 71. Mylan Recent Development
Table 72. Vertex Pharmaceuticals Company Information
Table 73. Vertex Pharmaceuticals Description and Business Overview
Table 74. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product
Table 76. Vertex Pharmaceuticals Recent Development
Table 77. F. Hoffman La Roche Company Information
Table 78. F. Hoffman La Roche Description and Business Overview
Table 79. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. F. Hoffman La Roche Lung Disease Therapeutic Drug Product
Table 81. F. Hoffman La Roche Recent Development
Table 82. Teva Pharmaceuticals Company Information
Table 83. Teva Pharmaceuticals Description and Business Overview
Table 84. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Teva Pharmaceuticals Lung Disease Therapeutic Drug Product
Table 86. Teva Pharmaceuticals Recent Development
Table 87. Cipla Company Information
Table 88. Cipla Description and Business Overview
Table 89. Cipla Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Cipla Lung Disease Therapeutic Drug Product
Table 91. Cipla Recent Development
Table 92. Fibrogen Company Information
Table 93. Fibrogen Description and Business Overview
Table 94. Fibrogen Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Fibrogen Lung Disease Therapeutic Drug Product
Table 96. Fibrogen Recent Development
Table 97. Liminal Biosciences Company Information
Table 98. Liminal Biosciences Description and Business Overview
Table 99. Liminal Biosciences Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Liminal Biosciences Lung Disease Therapeutic Drug Product
Table 101. Liminal Biosciences Recent Development
Table 102. PharmAkea Therapeutics Company Information
Table 103. PharmAkea Therapeutics Description and Business Overview
Table 104. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. PharmAkea Therapeutics Lung Disease Therapeutic Drug Product
Table 106. PharmAkea Therapeutics Recent Development
Table 107. IQVIA Company Information
Table 108. IQVIA Description and Business Overview
Table 109. IQVIA Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. IQVIA Lung Disease Therapeutic Drug Product
Table 111. IQVIA Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Lung Disease Therapeutic Drug Customers List
Table 115. Lung Disease Therapeutic Drug Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Disease Therapeutic Drug Product Picture
Figure 2. Global Lung Disease Therapeutic Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Lung Disease Therapeutic Drug Market Size 2018-2034 (US$ Million)
Figure 4. Global Lung Disease Therapeutic Drug Sales 2018-2034 (K Units)
Figure 5. India Lung Disease Therapeutic Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Lung Disease Therapeutic Drug Market Size 2018-2034 (US$ Million)
Figure 7. India Lung Disease Therapeutic Drug Sales 2018-2034 (K Units)
Figure 8. India Lung Disease Therapeutic Drug Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Lung Disease Therapeutic Drug Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Lung Disease Therapeutic Drug Report Years Considered
Figure 11. Product Picture of Corticosteroids
Figure 12. Product Picture of Bronchodilator Medications
Figure 13. Product Picture of Mucolytics
Figure 14. Product Picture of Antimicrobial Medications
Figure 15. Product Picture of Others
Figure 16. Global Lung Disease Therapeutic Drug Market Share by Type in 2024 & 2034
Figure 17. Global Lung Disease Therapeutic Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 18. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Type (2018-2034)
Figure 19. Global Lung Disease Therapeutic Drug Sales by Type (2018-2034) & (K Units)
Figure 20. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2018-2034)
Figure 21. Global Lung Disease Therapeutic Drug Price by Type (2018-2034) & (US$/Unit)
Figure 22. India Lung Disease Therapeutic Drug Market Share by Type in 2024 & 2034
Figure 23. India Lung Disease Therapeutic Drug Sales in Value by Type (2018-2034) & (US$ Million)
Figure 24. India Lung Disease Therapeutic Drug Sales Market Share in Value by Type (2018-2034)
Figure 25. India Lung Disease Therapeutic Drug Sales by Type (2018-2034) & (K Units)
Figure 26. India Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2018-2034)
Figure 27. India Lung Disease Therapeutic Drug Price by Type (2018-2034) & (US$/Unit)
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Product Picture of Retail Pharmacies
Figure 30. Product Picture of Online Pharmacies
Figure 31. Global Lung Disease Therapeutic Drug Market Share by Application in 2024 & 2034
Figure 32. Global Lung Disease Therapeutic Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 33. Global Lung Disease Therapeutic Drug Sales Market Share in Value by Application (2018-2034)
Figure 34. Global Lung Disease Therapeutic Drug Sales by Application (2018-2034) & (K Units)
Figure 35. Global Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2018-2034)
Figure 36. Global Lung Disease Therapeutic Drug Price by Application (2018-2034) & (US$/Unit)
Figure 37. India Lung Disease Therapeutic Drug Market Share by Application in 2024 & 2034
Figure 38. India Lung Disease Therapeutic Drug Sales in Value by Application (2018-2034) & (US$ Million)
Figure 39. India Lung Disease Therapeutic Drug Sales Market Share in Value by Application (2018-2034)
Figure 40. India Lung Disease Therapeutic Drug Sales by Application (2018-2034) & (K Units)
Figure 41. India Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2018-2034)
Figure 42. India Lung Disease Therapeutic Drug Price by Application (2018-2034) & (US$/Unit)
Figure 43. Americas Lung Disease Therapeutic Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 44. Americas Lung Disease Therapeutic Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 45. Americas Lung Disease Therapeutic Drug Sales by Type (2018-2034) & (K Units)
Figure 46. Americas Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2018-2034)
Figure 47. Americas Lung Disease Therapeutic Drug Sales by Application (2018-2034) & (K Units)
Figure 48. Americas Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2018-2034)
Figure 49. United States Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Canada Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Mexico Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. EMEA Lung Disease Therapeutic Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 54. EMEA Lung Disease Therapeutic Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 55. EMEA Lung Disease Therapeutic Drug Sales by Type (2018-2034) & (K Units)
Figure 56. EMEA Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2018-2034)
Figure 57. EMEA Lung Disease Therapeutic Drug Sales by Application (2018-2034) & (K Units)
Figure 58. EMEA Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2018-2034)
Figure 59. Europe Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Middle East Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Africa Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. China Lung Disease Therapeutic Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 63. China Lung Disease Therapeutic Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 64. China Lung Disease Therapeutic Drug Sales by Type (2018-2034) & (K Units)
Figure 65. China Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2018-2034)
Figure 66. China Lung Disease Therapeutic Drug Sales by Application (2018-2034) & (K Units)
Figure 67. China Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2018-2034)
Figure 68. APAC Lung Disease Therapeutic Drug Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 69. APAC Lung Disease Therapeutic Drug Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 70. APAC Lung Disease Therapeutic Drug Sales by Type (2018-2034) & (K Units)
Figure 71. APAC Lung Disease Therapeutic Drug Sales Market Share in Volume by Type (2018-2034)
Figure 72. APAC Lung Disease Therapeutic Drug Sales by Application (2018-2034) & (K Units)
Figure 73. APAC Lung Disease Therapeutic Drug Sales Market Share in Volume by Application (2018-2034)
Figure 74. Japan Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. South Korea Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. China Taiwan Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. India Lung Disease Therapeutic Drug Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. Lung Disease Therapeutic Drug Value Chain
Figure 80. Lung Disease Therapeutic Drug Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed